EPISODE · May 26, 2026 · 47 MIN
EP 64 | The Balance Between Data and Intuition in Health — Why Extreme Approaches Fail With Megan Morris
from Move Mountains Podcast · host Charlie White
Most health and wellness brands are missing a crucial edge — scientific validation. Megan Morris, founder of MOQ Collective, reveals how clinical trials and third-party testing are transforming a saturated industry. Learn why consumers are smarter, more skeptical, and demanding transparency — and how brands that invest in credible proof will win long-term trust. In this episode, Megan shares the surprising costs and strategies behind observational studies and randomized trials, showing you how to prove your product works and stand out. ABOUT THIS EPISODE: The critical role of third-party testing in building consumer confidence The difference between loose claims and rigorous clinical evidence How brands leverage white papers and science-backed marketing to differentiate in a crowded market The real costs of clinical trials and how startups can approach testing on a budget Why top brands prioritize transparency and third-party validation for longevity This conversation isn't just for entrepreneurs in health — it's a blueprint for any business aiming to build credibility and long-term trust in a data-driven world. If you're tired of the hype and eager to learn how science can elevate your brand, this episode is your must-listen. Plus, Megan, a seasoned nutrition expert and innovator, shares her personal transition from dogmatic nutrition advice to embracing balance, authenticity, and joy — reminding us that meaningful progress starts with honesty and small, intentional steps. Ready to turn scientific proof into your competitive advantage? Hit play now and see how investing in credible evidence can future-proof your brand and foster genuine trust with your audience.
NOW PLAYING
EP 64 | The Balance Between Data and Intuition in Health — Why Extreme Approaches Fail With Megan Morris
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m